Skip to main content

Advertisement

Log in

Motivating Patient Adherence to Allergic Rhinitis Treatments

  • Rhinitis (JJ Oppenheimer and J Corren, Section Editors)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Patient nonadherence significantly burdens the treatment of allergic rhinitis (AR). Fewer than half of prescribed doses of intranasal corticosteroid medication are taken. The challenges for immunotherapies are even greater. While sustained treatment for 3 to 5 years is required for full benefit, most patients receiving immunotherapy, either subcutaneous or sublingual, stop treatment within the first year. Although research into interventions to improve AR adherence is lacking, lessons learned from adherence interventions in other chronic health conditions can be applied to AR. Two well-established, overriding models of care—the chronic care model and patient-centered care—can improve adherence. The patient-centered care model includes important lessons for allergy providers in their daily practice, including understanding and targeting modifiable barriers to adherence. Additionally, recent studies have begun to leverage health information and communication technologies to reach out to patients and promote adherence, extending patient-centered interventions initiated by providers during office visits.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy. 2001;21:1464–7.

    Article  CAS  PubMed  Google Scholar 

  2. Bender B, Pedan A, Varasteh L. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol. 2006;118:899–904.

    Article  CAS  PubMed  Google Scholar 

  3. Vanelli M, Pedan A, Liu N, Hoar J, Messier D, Kiarsis K. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses. Clin Ther. 2009;31(11):2628–52. Provides a large-scale picture of the problem of nonadherence across medical conditions.

    Article  PubMed  Google Scholar 

  4. Evans C, Eurich D, Remillard A, Shevchuk Y, Blackburn D. First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study. Am J Hypertens. 2012;25(2):195–203.

    Article  CAS  PubMed  Google Scholar 

  5. Penning-van B, Van Herksukel M, Gale R, Lammers J, Herings R. Three-year dispensing patterns with long-acting inhaled drugs, in COPD: a database analysis. Respir Med. 2011;105(2):259–65.

    Article  Google Scholar 

  6. Bender B, Rankin A, Trans Z, Wamboldt F. Brief interval telephone surveys of medication adherence and asthma symptoms in the Childhood Asthma Management Program Continuation Study. Ann Allergy Asthma Immunol. 2008;101:382–6.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Williams L, Pladevall J, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288–93. One of the few studies demonstrating a direct relationship between asthma nonadherence and healthcare outcomes.

    Article  CAS  PubMed  Google Scholar 

  8. Rust G, Zhang S, Reynolds J. Inhaled corticosteroid adherence and emergency department utilization among Medicaid-enrolled children with asthma. J Asthma. 2013;50:769–75.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Williams L, Peterson E, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. Allergy Clin Immunol. 2011;128(6):1185–91.

    Article  Google Scholar 

  10. Hankin C, Cox L, Lang D, et al. Medical costs and adherence in patients receiving aqueous versus pressurized aerosol formulations of intranasal corticosteroids. Allergy Asthma Proc. 2012;33:258–64.

    PubMed  Google Scholar 

  11. Le T, Bilderback A, Bender B, et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? Asthma. 2008;45:33–7.

    Article  Google Scholar 

  12. Walders N, Kopel S, Koinis-Mitchelle D, McQuaid E. Patterns of quick-relief and long-term controller medication use in pediatric asthma. J Pediatr. 2005;146:177–82.

    Article  PubMed  Google Scholar 

  13. Mahadevia P, Shah S, Leibman C, Kleinman L, O’Dowd L. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Ann Allergy Asthma Immunol. 2001;93:345–50.

    Article  Google Scholar 

  14. Hellings P, Dobbels F, Denhaeryrick K, Piersens M, Ceuppes J, De Geest S. Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transit Allergy. 2012;2(1):9.

    Article  Google Scholar 

  15. Sher E, Ross J. Intranasal corticosteroids: the role of patient preference and satisfaction. Allergy Asthma Proc. 2014;35(1):24–33.

    Article  CAS  PubMed  Google Scholar 

  16. Marogna M, Spadolini I, Massolo A, Canonica G, Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol. 2010;126(5):969–75. Demonstrates the declining benefits of sublingual immunotherapy accompanying decreasing treatment intervals.

    Article  PubMed  Google Scholar 

  17. Hankin C, Cox L, Lang D, et al. Allergy immunotherapy among medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol. 2008;121:227–32.

    Article  PubMed  Google Scholar 

  18. Senna G, Lombardi C, Canonica G, Passalacqua G. How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers’ viewpoint. J Allergy Clin Immunol. 2010;126:668–9.

    Article  PubMed  Google Scholar 

  19. Kiel M, Roder E, Gerth van Wijk P, Al M, Hop W, Rutten-van Molken MPMH. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132:353–60. Provides a direct comparison between SLIT and SCIT adherence.

    Article  PubMed  Google Scholar 

  20. Shaw R, Bosworth H. Baseline medication adherence and blood pressure in a 24-month longitudinal hypertension study. J Clin Nurs. 2012;21:1401–6.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Wiegant P, McCombs J, Wang J. Factors of hyperlipidemia medication adherence in a nationwide health plan. Am J Manage Care. 2012;18:1930199.

    Google Scholar 

  22. Huetsch J, Uman J, Udris E, Au D. Predictors of adherence to inhaled medications among veterans with COPD. J Gen Intern Med. 2012;27(11):1506–12.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Nam S, Chesla C, Stotts N, Kroon L, Janson S. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1–9.

    Article  PubMed  Google Scholar 

  24. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.

    Article  CAS  PubMed  Google Scholar 

  25. Schiff G, Fung S, Speruff T, McNutt R. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114:625–30.

    Article  PubMed  Google Scholar 

  26. Senst B, Achusim L, Genest R. Practical approach to determine costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58:1126–32.

    CAS  PubMed  Google Scholar 

  27. Bosworth H, Grnater B, Mendys P. Medication adherence: a call for action. Am Heart. 2011;162:412–24.

    Article  Google Scholar 

  28. Desal M, Oppenheimer J. Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep. 2011;11(6):454–64.

    Article  Google Scholar 

  29. Drotar D, Bonner M. Influences on adherence to pediatric asthma treatment: a review of correlates and predictors. J Dev Behav Pediatr. 2009;30(6):574–82.

    Article  PubMed  Google Scholar 

  30. Hernandez D, Schmaling K. Understanding and resolving adherence problems. Clin Rev Allergy Immunol. 2004;27(2):65–73.

    Article  PubMed  Google Scholar 

  31. Bukstein D, Luskin A, Farrar J. The reality of adherence to rhinitis treatment: identifying and overcoming the barriers. Allergy Asthma Proc. 2011;32:265–71.

    Article  PubMed  Google Scholar 

  32. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130:65S–72.

    Article  PubMed  Google Scholar 

  33. Bender B, Bender S. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin N Am. 2005;25:107–30.

    Article  Google Scholar 

  34. Bender B, Long A, Parasuraman B, Tran Z. Factors influencing patient decisions about the use of asthma controller medication. Ann Asthma. 2007;98:322–8.

    Article  Google Scholar 

  35. Miller T, Dimattao M. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes. 2013;6(6):421–6.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Derose S, Green K, Marrett E, et al. Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med. 2013;173(1):38–43.

    Article  PubMed  Google Scholar 

  37. Wilson S, Strub P, Buist A, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–77. One of the best studies of the benefits of shared decision making to treatment adherence.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Renders C. Interventions to improve the management of diabetes mellitus in primary care, outpatient, and community settings. Cochrane Database of Syst Rev No 1. 2002;CD001481.

  39. Dickinson W, Dickinson L, Nutting P, et al. Practice facilitation to improve diabetes care in primary care: a report from the EPIC randomized clinical trial. Ann Fam Med. 2014;12(1):8–16.

    Article  PubMed Central  PubMed  Google Scholar 

  40. van Boven J, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Med. 2014:15–66.

  41. Lozano P, Finkelstein J, Carey V, et al. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med. 2004;158(9):875–83.

    Article  PubMed  Google Scholar 

  42. Bobbins L, Pfeiffer K, Maler K, LaDrig S, Malcolm B. Treatment fidelity of motivational interviewing delivered by a school nurse to increase girls’ physical activity. J Sch Nurs. 2012;February 28(1):70–78.

  43. Tollison S, Mastroleo N, Mallett K, Witkiewitz K, Ray A, Larimer M. The relationship between baseline drinking status, peer motivational interviewing microskills and drinking outcomes in a brief alcohol intervention for matriculating college students. A replication. Behav Ther. 2013;44(1):137–51.

    Article  PubMed Central  PubMed  Google Scholar 

  44. D’Amico E, Hunter S, Miles J, Ewing B, Osilla K. A randomized controlled trial of a group motivational interviewing intervention for adolescents with a first time alcohol or drug offense. J Subst Abuse Treat. 2013;45(5).

  45. Cook P, Bremer R, Ayala A, Kahook MY. Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence. Clin Ophthalmol. 2010;4:1091–101.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Barkhof E, Meijer C, de Sonneville L, Linszen D, de Haan L. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophr Bull. 2013;39(6):1242–51.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Bender B. Can healthcare organizations improve health behavior and treatment adherence? Popul Health Manag. 2014;17:71–8.

    Article  PubMed  Google Scholar 

  48. Bender B. Nonadherence to COPD treatment: what have we learned and what do we do next? COPD. 2012;9:209–10.

    Article  PubMed  Google Scholar 

  49. Bender B. Communication strategies to improve adherence with asthma medications. Vol Pediatric Allergy: Principles and Practice. New York, NY: Elsevier; 2010

  50. Essential elements of communication in medical encounters: the Kalamazoo Consensus Statement. Paper presented at: Bayer-Fetzer Conference on Physician-Patient Communication in Medical Education 20012001.

  51. DiMatteo M. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Couns. 2004;55:339–44.

    Article  PubMed  Google Scholar 

  52. Boulware L, Daumit G, Frick K, Minkovitz C, Lawrnece R, Powe N. An evidence-based review of patient-centered behavioral interventions for hypertension. Am J Prev Med. 2001;1(21):221–32.

    Article  Google Scholar 

  53. Borrelli B, Riekert K, Weinstien A. Brief motivational interviewing as a clinical strategy to promote asthma medication adherence. J Allergy Clin Immunol. 2007;120(5):1023–30.

    Article  PubMed  Google Scholar 

  54. Wamboldt F, Bender B. Adolescent decision-making about use of inhaled asthma controller medication: results from focus groups with participants from a prior longitudinal study. J Asthma. 2011;48:741–50.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Dalcin Pde T, Grutcki D, Laporte P, et al. Impact of a short-term educational intervention on adherence to asthma treatment and on asthma control. J Bras Pneumol. 2011;37:19–27.

    Article  PubMed  Google Scholar 

  56. Irwin R, Richardson N. Patient-focused care: using the right tools. 2006;130:73–82. A clear and concise exploration of the importance of patient-centered care.

  57. Linnemann D, Blaiss M. Selection of patient for sublingual versus subcutaneous immunotherapy. Immunotherapy. 2014;6(7):871–84.

    Article  Google Scholar 

  58. Sher E, Ross J. Intranasal corticosteroids: the role of patient preference and satisfaction. Allergy Asthma Proc. 2014;35(Number 1):24–33.

    Article  CAS  PubMed  Google Scholar 

  59. Noble P, Fuller-Lafreniere S, Meftah M, Dwyer M. Challenges in outcome measurement: discrepancies between patient and provider definitions of success. Clin Orthop Relat Res. 2013;471(11):3437–45.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Wilson S, Strub P, Buist A, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Better Outcomes of Asthma Treatment (BOAT) Study Group. Am J Respir Crit Care Med. 2010;181(6):566–77.

    Article  PubMed Central  PubMed  Google Scholar 

  61. Bosworth H, Olsen M, Neasry A, et al. Take control of your blood pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008;70:338–47.

    Article  PubMed Central  PubMed  Google Scholar 

  62. Ziller V, Kyvenmitakis I, Knoll D, Storch A, Hars O, Hadji P. Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment—the COMPAS study. BMC Cancer. BMC Cancer. 2013;(13):407.

  63. Montes J, Gomez-Beneyto M, Maurino J. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Res. 2012;(2–3):89–95.

  64. Stacy J, Schwartz S, Ershoff D, Shreve M. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12(5):241–54.

    Article  PubMed  Google Scholar 

  65. Vollmer W, Krishner M, Peter S, et al. Use and impact of an automated telephone outreach system for asthma in a managed care setting. Am J Manage Care. 2006;12:725–33.

    Google Scholar 

  66. Bender B, Cvietusa P, Goodrich G, et al. A pragmatic controlled trial of healthcare technologies to improve adherence to pediatric asthma treatment. JAMA Pediatr. In press. Demonstrates utilization of health information and communication technology to improve adherence.

  67. Wang K, Wang C, Xi L, et al. A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message services (SMS) via the mobile phone. Int Arch Allergy Immunol. 2013;163(1):51–8.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Bruce Bender declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruce G. Bender.

Additional information

This article is part of the Topical Collection on Rhinitis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bender, B.G. Motivating Patient Adherence to Allergic Rhinitis Treatments. Curr Allergy Asthma Rep 15, 10 (2015). https://doi.org/10.1007/s11882-014-0507-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-014-0507-8

Keywords

Navigation